Handelsavisen
prelaunch
Companies ›Healthcare ›INNV.O
IN
INNV.O — NASDAQ Health Care Providers & Services

Innv.O

$11,46
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
1,6B USD
P/E
—
EV / Rev
1,6x
Div yield
—
Op margin
-1,0 %
ROE
-4,9 %
Net margin
-1,2 %
Debt / equity
0,24
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$11,23
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About

INNV.O is a health care provider or service entity, as indicated by its sector classification classification, though specific operational details and revenue generation mechanisms are not disclosed in the available data.

Business. INNV.O is a health care provider or service entity, as indicated by its sector classification classification, though specific operational details and revenue generation mechanisms are not disclosed in the available data.

Classification85 %
SectorHealth Care
Industry groupHealth Care Providers & Services
Generated · model-assisted
Sell-side consensus
HOLD4 analysts
0 buy3 hold1 sell
Avg 12m price target7,00

Analyst recommendations

4 analysts · consensus Hold
Buy0
Hold3
Sell1
12-month price target
7,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts→
Hold
4 analysts · indicative
Ownership→
T. Rowe Price Investment Management, Inc.
largest disclosed fund holder
Profitability→
-4,9 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning INNV.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to INNV.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    INNV.O is a health care provider or service entity, as indicated by its sector classification classification, though specific operational details and revenue generation mechanisms are not disclosed in the available data.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Providers & Services
    AI synthesis
    GENERATED
    — missing data
    Key takeaways
    • The company generates positive operating cash flow ($32.87M) despite reporting a net loss ($30.31M), indicating strong cash conversion or non-cash expense drivers.
    • Analyst sentiment is cautious, with a mean price target of $7.00, significantly below the current market price of $11.46.
    • Profitability is negative, with ROE at -4.94% and ROA at -2.20%, driven by operating expenses exceeding gross profit.
    • Capital structure is conservative with a low debt-to-equity ratio of 0.24 and no immediate dilution risks.
    • Liquidity is rated as low, though the company holds $64.13M in cash against $57.46M in long-term debt.
    • Historical growth data and segment breakdowns are unavailable, limiting trend and concentration analysis.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-05
    Q1 2026 · Quarter highlights
    Open report →

    Revenue $251.9M, +15,5% YoY; Operating income −186,3% YoY.

    Revenue$251.9M+15,5 % YoY
    Operating income-$29.1M−186,3 % YoY
    Net income-$29.5M−158,9 % YoY
    Free cash flow-$28.6M−231,8 % YoY
    EPS—
    Operating cash flow$43.3M+81,6 % YoY
    Financials
    Income statement
    Revenue$251.9M
    Gross profit$61.0M
    Operating income-$29.1M
    Net income-$29.5M
    Margins
    Gross margin24.2%
    Operating margin-11.5%
    Net margin-11.7%
    FCF margin-11.4%
    Balance sheet
    Total assets$547.4M
    Total liabilities$318.4M
    Total equity$229.0M
    Cash & equivalents$95.5M
    Long-term debt$68.6M
    Cash flow
    Operating cash flow$43.3M
    CapEx-$10.0M
    Free cash flow-$28.6M
    SBC—
    P&L flow · revenue → net income
    Revenue $251.9MOperating costs $281.0MTax $382.0kNet income $29.5M
    Highlights
    • ▍Revenue $251.9M, +15,5% YoY
    • ▍Operating income −186,3% YoY
    • ▍Net income −158,9% YoY
    • ▍Free cash flow −231,8% YoY
    • ▍Net margin -11.7%

    Valuation TTM

    Market price
    $11,46
    Market cap
    $1.55B
    Enterprise valueⓘ
    $1.55B
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    1.6x
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    47.0x
    P / Bⓘ
    5.9x
    P / Tangible bookⓘ
    5.9x
    Tangible book
    $262.9M
    Net cashⓘ
    $6.7M
    Current ratioⓘ
    —
    Debt / equityⓘ
    0.2
    ROAⓘ
    -2.2%
    ROEⓘ
    -4.9%
    Cash conversionⓘ
    -283.0%
    CapEx / revenueⓘ
    -0.7%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships31 disclosed relationships · 1 type · extracted from filings & disclosures
    Subsidiaries31
    EX21:00da460698b8EX21:00da460698b8Subsidiarie97%
    EX21:142830a850a5EX21:142830a850a5Subsidiarie97%Source ↗
    EX21:1738d2c3ea21EX21:1738d2c3ea21Subsidiarie97%
    EX21:314f37068528EX21:314f37068528Subsidiarie97%
    EX21:32fe5794bf6cEX21:32fe5794bf6cSubsidiarie97%
    EX21:3908537eb0c2EX21:3908537eb0c2Subsidiarie97%
    EX21:4b05aba7baf3EX21:4b05aba7baf3Subsidiarie97%
    EX21:5173c71e65faEX21:5173c71e65faSubsidiarie97%Source ↗
    EX21:572d8016dd7aEX21:572d8016dd7aSubsidiarie97%
    EX21:5840596f90c6EX21:5840596f90c6Subsidiarie97%
    EX21:58b8a7ee8f27EX21:58b8a7ee8f27Subsidiarie97%
    EX21:627d595b1b73EX21:627d595b1b73Subsidiarie97%
    EX21:6923dd7df2fcEX21:6923dd7df2fcSubsidiarie97%
    EX21:791300c76205EX21:791300c76205Subsidiarie97%
    EX21:87a2059a04b6EX21:87a2059a04b6Subsidiarie97%
    EX21:87c20a71f4cfEX21:87c20a71f4cfSubsidiarie97%
    EX21:98b7bedccaa3EX21:98b7bedccaa3Subsidiarie97%
    EX21:a525853977ffEX21:a525853977ffSubsidiarie97%
    EX21:b1060abe1e50EX21:b1060abe1e50Subsidiarie97%
    EX21:b7d7b9d2d143EX21:b7d7b9d2d143Subsidiarie97%
    EX21:b89ad681ca80EX21:b89ad681ca80Subsidiarie97%
    EX21:bbb0b016c1afEX21:bbb0b016c1afSubsidiarie97%
    EX21:bcc61973a451EX21:bcc61973a451Subsidiarie97%Source ↗
    EX21:c6028919d221EX21:c6028919d221Subsidiarie97%
    EX21:cd0ba5fed9cdEX21:cd0ba5fed9cdSubsidiarie97%
    EX21:e4164139c3d1EX21:e4164139c3d1Subsidiarie97%
    EX21:e436883c65f8EX21:e436883c65f8Subsidiarie97%
    EX21:e731d1ca46a3EX21:e731d1ca46a3Subsidiarie97%
    EX21:f04e1795685fEX21:f04e1795685fSubsidiarie97%
    EX21:f95edd5d0109EX21:f95edd5d0109Subsidiarie97%
    EX21:fca48a13a2a1EX21:fca48a13a2a1Subsidiarie97%

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution4 analysts
    Strong buy0
    Buy0
    Hold3
    Sell1
    Strong sell0
    12-month price target$7,00 · Median $7,00
    Low $7,00High $7,00
    Operating income · consensus25,8M USD
    EPS surprise
    −2 100,0 %
    reported vs consensus · miss
    Revenue surprise
    −11,6 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$7,00
    Mean$7,00
    Median$7,00
    High$7,00
    Spot$11,46
    −38.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin-1,0 %Below median
    Net Margin-1,2 %Above median
    ROE-4,9 %Below median
    Capex / Rev-0,7 %Below median
    D/E0,24Below median
    Cash Conv-2,83Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • InnovAge Holding Corp. Market data — financials · 2026-08-04
    • failed_redrive (failed_redrive) on INNV.O · 2026-08-04
    • InnovAge Holding Corp Market data — analyst estimates · 2026-08-04
    • InnovAge Holding Corp Market data — ESG · 2026-08-04
    • INNV.O HA canonical relationships · 2026-08-04

    Ownership & reference

    Top holders

    • T. Rowe Price Investment Management, Inc.Investment Managers · as of 2026-03-310,03 %$0M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,00 %$3M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$2M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$5M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$2M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$6M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$3M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$6M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$0M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Patrick BlairPresident, Chief Executive Officer

    Insider activity

    Net selling0 buys · 1 sellsnet -$162K13 insiders · last 365d
    • BLAIR PATRICK TCHIEF EXECUTIVE OFFICER · Common Stock, $0.001 par valueOther 78 397 · 2026-07-27
    • DAMATO NICOLECHIEF LEGAL OFFICER · Common Stock, $0.001 par valueOther 51 369 · 2026-07-22
    • Delk MeredithChief Administrative Officer · Common Stock, $0.001 par valueOther 42 808 · 2026-07-22
    • Adams Benjamin CCHIEF FINANCIAL OFFICER · Common Stock, $0.001 par valueOther 17 123 · 2026-07-22
    • BLAIR PATRICK TCHIEF EXECUTIVE OFFICER · Common Stock, $0.001 par valueOther 14 453 @ $11,87$172K · 2026-07-16
    • DAMATO NICOLECHIEF LEGAL OFFICER · Common Stock, $0.001 par valueOther 19 401 @ $11,58$225K · 2026-07-15
    • FONTNEAU PATRICIADirector · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • ZORETIC RICHARD CDirector · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • CARLSON JAMES GDirector · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • Bush John EllisDirector · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • Kennedy Edward Moore Jr.Director · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • Sparks TeresaDirector · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • TAVENNER MARILYN BDirector · Common Stock, $0.001 par valueOther 8 539 · 2026-07-01
    • Browne JenniferPresident and COO · Common Stock, $0.001 par valueOther 67 842 · 2026-06-08
    • BLAIR PATRICK TCHIEF EXECUTIVE OFFICER · Common Stock, $0.001 par valueOther 10 088 @ $7,30$74K · 2026-06-06
    • DAMATO NICOLECHIEF LEGAL OFFICER · Common Stock, $0.001 par valueOther 8 018 @ $7,30$59K · 2026-06-06
    • BLAIR PATRICK TCHIEF EXECUTIVE OFFICER · Common Stock, $0.001 par valueOther 11 881 @ $7,30$87K · 2026-06-05
    • DAMATO NICOLECHIEF LEGAL OFFICER · Common Stock, $0.001 par valueOther 15 046 @ $7,20$108K · 2026-06-04
    • BLAIR PATRICK TCHIEF EXECUTIVE OFFICER · Common Stock, $0.001 par valueOther 5 054 @ $5,47$28K · 2025-12-01
    • SCARBROUGH MICHAEL ANTHONYPresident and COO · Common Stock, $0.001 par valueSold 33 000 @ $4,90$162K · 2025-11-14
    • BLAIR PATRICK TCHIEF EXECUTIVE OFFICER · Common Stock, $0.001 par valueOther 5 056 @ $3,83$19K · 2025-09-01
    • DAMATO NICOLECHIEF LEGAL OFFICER · Common Stock, $0.001 par valueOther 14 303 @ $3,43$49K · 2025-08-15

    Short positioning

    1.0Mshares short-10.2% vs prior
    3.16days to cover
    58.4%short of daily vol
    1.4Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    INNV.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.
    Relationship graph
    INNVEX21:00dEX21:142EX21:173EX21:314EX21:32fEX21:390EX21:4b0EX21:517EX21:572EX21:584Health Care Pr
    This companySectorSubsidiaries

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage